Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Usefulness of prescription monitoring programs for surveillance--analysis of Schedule II opioid prescription data in Massachusetts, 1996-2006.

Katz N, Panas L, Kim M, Audet AD, Bilansky A, Eadie J, Kreiner P, Paillard FC, Thomas C, Carrow G.

Pharmacoepidemiol Drug Saf. 2010 Feb;19(2):115-23. doi: 10.1002/pds.1878.

PMID:
20014166
2.

The influence of prescription monitoring programs on chronic pain management.

Wang J, Christo PJ.

Pain Physician. 2009 May-Jun;12(3):507-15.

3.

Do prescription monitoring programs impact state trends in opioid abuse/misuse?

Reifler LM, Droz D, Bailey JE, Schnoll SH, Fant R, Dart RC, Bucher Bartelson B.

Pain Med. 2012 Mar;13(3):434-42. doi: 10.1111/j.1526-4637.2012.01327.x. Epub 2012 Feb 2.

PMID:
22299725
4.

Prescriptions for schedule II opioids and benzodiazepines increase after the introduction of computer-generated prescriptions.

McGerald G, Dvorkin R, Levy D, Lovell-Rose S, Sharma A.

Acad Emerg Med. 2009 Jun;16(6):508-12. doi: 10.1111/j.1553-2712.2009.00398.x. Epub 2009 Apr 21.

5.

Analytic models to identify patients at risk for prescription opioid abuse.

White AG, Birnbaum HG, Schiller M, Tang J, Katz NP.

Am J Manag Care. 2009 Dec;15(12):897-906.

6.

National drug control policy and prescription drug abuse: facts and fallacies.

Manchikanti L.

Pain Physician. 2007 May;10(3):399-424. Review.

7.

Time series analysis of California's prescription monitoring program: impact on prescribing and multiple provider episodes.

Gilson AM, Fishman SM, Wilsey BL, Casamalhuapa C, Baxi H.

J Pain. 2012 Feb;13(2):103-11. doi: 10.1016/j.jpain.2011.09.006. Epub 2011 Nov 23.

8.

Differences and over-time changes in levels of prescription opioid analgesic dispensing from retail pharmacies in Canada, 2005-2010.

Fischer B, Jones W, Krahn M, Rehm J.

Pharmacoepidemiol Drug Saf. 2011 Dec;20(12):1269-77. doi: 10.1002/pds.2190. Epub 2011 Jul 13.

PMID:
21755568
9.
10.
11.

Screening for potential prescription opioid misuse in a michigan medicaid population.

Braker LS, Reese AE, Card RO, Van Howe RS.

Fam Med. 2009 Nov-Dec;41(10):729-34.

12.

Gender and non-medical use of prescription opioids: results from a national US survey.

Tetrault JM, Desai RA, Becker WC, Fiellin DA, Concato J, Sullivan LE.

Addiction. 2008 Feb;103(2):258-68. Epub 2007 Nov 27.

PMID:
18042194
13.

Distance traveled and frequency of interstate opioid dispensing in opioid shoppers and nonshoppers.

Cepeda MS, Fife D, Yuan Y, Mastrogiovanni G.

J Pain. 2013 Oct;14(10):1158-61. doi: 10.1016/j.jpain.2013.04.014. Epub 2013 Jun 20.

14.

Impact of a managed controlled-opioid prescription monitoring program on care coordination.

Gonzalez AM 3rd, Kolbasovsky A.

Am J Manag Care. 2012 Sep;18(9):516-24.

15.

Characteristics of prescribers whose patients shop for opioids: results from a cohort study.

Cepeda MS, Fife D, Berlin JA, Mastrogiovanni G, Yuan Y.

J Opioid Manag. 2012 Sep-Oct;8(5):285-91. doi: 10.5055/jom.2012.0128.

PMID:
23247905
16.

Opioid shopping behavior: how often, how soon, which drugs, and what payment method.

Cepeda MS, Fife D, Chow W, Mastrogiovanni G, Henderson SC.

J Clin Pharmacol. 2013 Jan;53(1):112-7. doi: 10.1177/0091270012436561. Epub 2013 Jan 24.

PMID:
23400751
17.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.

PMID:
18503626
18.

Effect of a triplicate prescription law on prescribing of Schedule II drugs.

Sigler KA, Guernsey BG, Ingrim NB, Buesing AS, Hokanson JA, Galvan E, Doutré WH.

Am J Hosp Pharm. 1984 Jan;41(1):108-11.

PMID:
6695926
19.
20.

How does use of a prescription monitoring program change medical practice?

Green TC, Mann MR, Bowman SE, Zaller N, Soto X, Gadea J, Cordy C, Kelly P, Friedmann PD.

Pain Med. 2012 Oct;13(10):1314-23. doi: 10.1111/j.1526-4637.2012.01452.x. Epub 2012 Jul 30.

PMID:
22845339

Supplemental Content

Support Center